id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-5139-0007,FDA,FDA-2024-E-5139,"Request for Redetermination from Merchant & Gould PC (on behalf of Hologic, Inc.)",Other,Request,2026-01-21T05:00:00Z,2026,1,2026-01-21T05:00:00Z,,2026-01-22T01:12:29Z,,0,0,09000064b91375c3
FDA-2024-E-5139-0006,FDA,FDA-2024-E-5139,Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM,Notice,Determinations,2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,2026-05-27T03:59:59Z,2026-01-24T13:16:48Z,2025-20667,1,0,09000064b908e3ef
FDA-2024-E-5139-0005,FDA,FDA-2024-E-5139,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-08-27T04:00:00Z,2025,8,2025-08-27T04:00:00Z,,2025-08-27T22:20:10Z,,0,0,09000064b8f19416
FDA-2024-E-5139-0004,FDA,FDA-2024-E-5139,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-06-17T04:00:00Z,2025,6,2025-06-17T04:00:00Z,,2025-06-18T00:39:58Z,,0,0,09000064b8e16a19
FDA-2024-E-5139-0003,FDA,FDA-2024-E-5139,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-03-18T04:00:00Z,2025,3,2025-03-18T04:00:00Z,,2025-03-18T14:28:40Z,,0,0,0900006486a0121c
FDA-2024-E-5139-0001,FDA,FDA-2024-E-5139,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,,2024-11-12T22:19:50Z,,0,0,09000064867f4bed
FDA-2024-E-5139-0002,FDA,FDA-2024-E-5139,"Patent Extension Application from c/o Merchant & Gould PC (on behalf of Hologic, Inc.)",Other,Application,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,,2024-11-12T22:19:53Z,,0,0,09000064867f4bee